A Pharmacokinetic Study to Compare Co-administration of Repaglinide and Metformin HCl to Administration of Combination Preparation of Those Two Components

Clinical trial NCT01780051 · COMPLETED

Trial details

NCT number

NCT01780051

Sponsor

Dalim BioTech Co., Ltd.

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-03-01

Primary completion

2013-04-01

Enrollment

48

View on ClinicalTrials.gov